Practical considerations for creating a strategic and proactive clinical safety and pharmacovigilance organization for the future

CONCLUSIONS: With >3 years of observation time, this project has provided AstraZeneca with a PS organisation able to provide strategic safety, supporting successful portfolio delivery, while ensuring patient safety and maintaining compliance with global pharmacovigilance regulations. It has driven efficiency and set the foundation for continued organisational evolution to meet future business needs in an everchanging environment.PMID:33579878 | DOI:10.3233/JRS-200082
Source: International Journal of Risk and Safety in Medicine - Category: Drugs & Pharmacology Authors: Source Type: research